CorMedix Inc. · SWB:19KA

CorMedix Inc. financial statements

CorMedix Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue311.7M43.5M065.4K190.9K239.2K283.3K429.8K329.3K224.1K
Cost of revenue22.1M3.03M205.6K3.73K148.9K204.8K373.2K396.8K115.0K366.7K
Gross profit275.7M40.3M-205.6K61.7K42.0K34.4K-90.0K33.0K214.4K-142.6K
Research and development19.3M3.94M13.2M10.7M13.1M13.4M11.1M18.8M24.5M15.7M
Selling, general and administrative68.2M30.0M35.8M20.0M16.3M13.9M9.87M8.07M8.65M8.88M
Operating income150.1M-22.4M-49.0M-30.6M-29.4M-27.2M-21.0M-26.9M-32.9M-24.8M
Depreciation and amortization677.0K154.0K70.8K84.6K61.9K128.0K73.3K74.2K36.9K25.6K
EBITDA150.8M-22.2M-48.9M-30.5M-29.4M-27.1M-20.9M-26.8M-32.9M-24.7M
Interest expense2.78M36.0K34.3K26.5K15.9K33.2K787.5K1.87K5.62K1.31K
Income before tax150.0M-19.3M-46.3M-30.3M-29.5M-27.2M-21.5M-26.8M-33.0M-24.6M
Income tax-13.0M-1.40M-2-585.6K-1.25M-5.17M-5.06M36.4K-31.3K1.31K
Net income163.1M-17.9M-46.3M-29.7M-28.2M-22.0M-16.4M-26.8M-33.0M-24.6M
Earnings per share, basic2.25-0.30-0.91-0.74-0.75-0.77-1.80-1.51-0.60-0.65
Earnings per share, diluted2.04-0.30-0.91-0.74-0.75-0.77-1.80-1.51-0.60-0.65

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents144.8M40.7M43.6M43.1M53.3M41.9M16.4M17.6M10.4M8.06M
Short-term investments3.69M11.0M32.4M15.6M12.1M4.44M12.0M01.60M12.1M
Receivables171.2M51.7M0045.4K3.36K3510.9K64.1K12.0K
Inventory29.7M7.60M2.11M03.01K143.6K338.5K428.5K594.2K166.7K
Current assets367.1M114.6M79.5M59.6M66.5M48.2M29.3M18.7M13.3M21.8M
Property, plant and equipment5.96M1.83M1.87M1.61M1.47M111.5K122.1K160.9K186.3K69.7K
Goodwill30.0M1.84B00
Total assets826.1M118.8M82.1M62.0M68.9M49.3M29.5M18.8M13.5M21.9M
Accounts payable7.88M1.72M4.28M2.20M2.21M1.13M1.02M2.59M1.81M1.65M
Current liabilities174.3M33.8M11.4M6.31M5.35M4.16M5.83M7.77M6.26M4.09M
Long-term debt144.6M6.13M00
Total debt148.9M517.0K667.6K802.4K923.8K1.03M4.69K6.13M
Total liabilities420.8M34.2M11.9M6.98M6.15M5.09M5.83M13.9M6.26M4.09M
Shareholders' equity405.3M84.7M70.1M55.1M62.8M44.2M23.6M4.93M7.19M17.8M
Shares outstanding79.3M64.4M54.9M42.8M38.1M33.6M25.7M21.8M71.4M40.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations175.0M-50.6M-38.4M-24.4M-21.2M-22.0M-15.1M-23.7M-28.6M-22.3M
Capital spending-2.26M-116.0K-327.3K-219.4K-1.43M-112.6K-36.6K-48.9K-152.0K-58.7K
Free cash flow172.8M-50.7M-38.7M-24.6M-22.6M-22.1M-15.1M-23.7M-28.7M-22.3M
Cash from investing-308.4M21.2M-17.1M-3.71M-9.13M7.43M-12.0M1.56M10.4M11.4M
Cash from financing238.5M26.3M55.9M17.9M41.8M40.1M25.8M29.4M20.5M7.09M
Dividends paid00
Share buybacks-198.4K41.8M40.1M26.0M22.0M20.5M7.09M
Change in cash105.1M-3.07M448.4K-10.2M11.5M25.6M-1.27M7.24M2.32M-3.75M